Corneal Cross-linking (CXL) was approved for the treatment of keratoconus in 2016. Many of you wearing scleral lenses have keratoconus, and CXL is the sole treatment for progression. Glaukos is the sole provider of FDA-approved corneal cross-linking in the United States. To find a corneal cross-linking specialist through Glaukos, click here
Still learning about how corneal cross-linking can be used to treat your keratoconus? Watch the webinar below, presented by SLS fellow Dr. John Gelles as he discusses corneal cross-linking for keratoconus.